Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Latasa

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repairOihane Garcia-Irigoyen, Simone Carotti, Maria U Latasa, et al.
Cell Death & Disease|October 6, 2017
Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in miceGloria Alvarez-Sola, Iker Uriarte, Maria U Latasa, et al.
Hepatology (Baltimore, Md.)|November 10, 2018
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids SynthesisEva Santamaría, Carlos M Rodríguez-Ortigosa, Iker Uriarte, et al.
Clinical Science (London, England : 1979)|September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell ReprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Journal of Hepatology|April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Gut|September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinomaJasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Nature Communications|November 26, 2022
Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damageIrene González-Recio, Jorge Simón, Naroa Goikoetxea-Usandizaga, et al.
Cancers|June 25, 2020
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning ApproachJesús M Urman, José M Herranz, Iker Uriarte, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repairOihane Garcia-Irigoyen, Simone Carotti, Maria U Latasa, et al.
Cell Death & Disease|October 6, 2017
Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in miceGloria Alvarez-Sola, Iker Uriarte, Maria U Latasa, et al.
Hepatology (Baltimore, Md.)|November 10, 2018
The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids SynthesisEva Santamaría, Carlos M Rodríguez-Ortigosa, Iker Uriarte, et al.
Clinical Science (London, England : 1979)|September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell ReprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Journal of Hepatology|April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Gut|September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinomaJasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Nature Communications|November 26, 2022
Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damageIrene González-Recio, Jorge Simón, Naroa Goikoetxea-Usandizaga, et al.
Cancers|June 25, 2020
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning ApproachJesús M Urman, José M Herranz, Iker Uriarte, et al.
Pageof 4